Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Schweizerische medizinische Wochenschrift 1980-Nov

[Thymoma: therapeutic and diagnostic aspects].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
E Walther

Märksõnad

Abstraktne

Ten patients with malignant inoperable thymoma were treated January 1972 and December 1978 in the Department of Radiotherapy, University Hospital, Basel. The average age at the time of diagnosis was 36 years. The youngest patient with an ectopic thymoma was 5 1/2 years old and the oldest 66. Accompanying autoimmune diseases were not observed. Histological verification was obtained 9 times by biopsy and once by tumor excision: 3 patients had a fusiform cell thymoma, 3 presented with a mixed-cell thymoma, 2 patients had a granulomatous and 2 mainly an epithelial or unclassified type of thymoma. Four patients died. One died within one year from generalized varicella infection and was free from tumor at autopsy. The other three developed metastases later. One developed a recurrence 2 1/2 years after receiving 6500 rads; following resection, a radiogold implant was given and additional irradiation of 4000 rad administered. Eighteen months later this patient developed lung metastases which exhibited slow progression under chemotherapy. 5 3/12 years after beginning of treatment laminectomy was performed, in the postoperative phase of which the patient contracted edema of the lung and died. The operation site showed a large recurrence invading the spinal channel per continuitatem. The other two patients died 1 3/12 years after the beginning of radiotherapy in spite of chemotherapy for disseminated metastases. Six patients who have been followed-up for one to 5 5/12 years are asymptomatic and show no evidence of disease. The dose administered was 4200-6500 rads. The therapeutic approach and factors affecting prognosis are discussed. In the experience of the authors and others, the best results are achieved with surgery and curative irradiation.

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge